Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DiLab is a Swedish life science technology company that specializes in the development and manufacturing of automated blood sampling systems for preclinical research. The company's flagship product, the AccuSampler, is designed to automate the collection of blood samples from laboratory animals, significantly reducing animal stress and handling. This technology is essential for improving the accuracy and reproducibility of pharmacokinetic (PK) and pharmacodynamic (PD) data in drug development. By enabling remote and programmed sampling, DiLab supports the 3Rs principles of animal welfare—Replacement, Reduction, and Refinement. The company serves a global clientele, including major pharmaceutical corporations, contract research organizations (CROs), and academic research centers. DiLab's solutions are integral to the early-stage drug discovery process, ensuring high-quality physiological data.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DiLab.